Retirement

30th June, 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400001 Bandra (E) Mumbai 400051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub:- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above cited subject, we would like to inform you that in accordance with the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Nadella Malleswara Rao, Vice President - Operations, Pharma Division – Kothur of the Company has superannuated today i.e., with effect from the closure of business hours on 30th June, 2026. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 and SEBI Master Circular No.HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 updated on January 30, 2026 are as under: Sl. No. Particulars 1 Name Nadella Malleswara Rao 2 Reason for Change in Senior Superannuation as Vice President - Operations, Pharma Management Division – Kothur of the Company 3 Date of appointment/re- With effect from the closure of business hours on 30th appointment/cessation (as June, 2026, Mr. Nadella Malleswara Rao has applicable) & term of superannuated and shall cease to be Vice President – appointment/re-appointment Operations, Pharma Division – Kothur of the Company 4 Brief profile Not Applicable 5 Disclosure of relationship Not Applicable between Directors This is for your information and records. Thanking you, Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer